Skip to main content

Joaquin Ruiz Altarejos

Joaquin Ruiz Altarejos

Related news

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.

Related professionals

Neus  Castells  Sarret

Neus Castells Sarret

Postdoctoral researcher
Genetics Medicine
Read more
Jorge Lugo Marin

Jorge Lugo Marin

Research technician
Psychiatry, Mental Health and Addictions
Read more
Almudena Sanchez Garcia

Almudena Sanchez Garcia

Research technician
Head and Neck Cancer: Biomedical Research Cancer Stem cells
Read more
Romy Gander

Romy Gander

Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.